Trial intelligence / Profile preview

Effect of liraglutide on vascular inflammation in type 2 diabetes

2016-001523-31Phase 4Completed

Sponsor
Steno Diabetes Center Copenhagen
Start
Nov 2016
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and diabetes mellitus (DM) comparing Liraglutide with Placebo (2 arms). Started Nov 2016; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)diabetes mellitus (DM)

Beyond the preview

Go deeper on 2016-001523-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001523-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call